Fundz

858 Therapeutics reported raising $25.2 Million in an initial SEC Form D filing, from an offering of $50.4 Million

PRIVATEJul 11, 2024$25.2M of $50.4M raised

Amount Raised

$25.2 Million

$25.2 Million per company press release (Sep 26, 2024)

Round Type

Venture

San DiegoBiotechnologyHealth CareScience And Engineering

Quick answer

858 Therapeutics raised $25.2 Million in a funding round, dated June 26, 2024. 858 Therapeutics is based in San Diego, California, United States.

How much did 858 Therapeutics raise?
858 Therapeutics raised $25.2 Million in a funding round on June 26, 2024.
What does 858 Therapeutics do?
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecules directed against novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune..
Where is 858 Therapeutics based and how big is it?
858 Therapeutics is based in San Diego, California, United States.
Who are the decision-makers at 858 Therapeutics?
Fundz holds 1 contact at 858 Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as 858 Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Cardurion Pharmaceuticals raised $260M (Series B) on July 16, 2024.
  • Cardurion Pharmaceuticals raised $260M (Series B) on July 16, 2024.
  • Cardurion Pharmaceuticals raised $260M on July 10, 2024.
  • Xtant Medical Holdings raised $5M on August 9, 2024.
  • BAIBYS raised $4.5M (Series A) on August 8, 2024.
  • clare&me raised $4M (Series A) on August 8, 2024.

Who to call at 858 Therapeutics, and when

A new round usually means 858 Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day 858 Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 858 Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 858 Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

858 Therapeutics

Location

San Diego, California, United States

About

858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecules directed against novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response. The company has built a platform to assess the impact of RNA-modifying proteins on disease biology and has generated a pipeline of small molecules against priority targets. 858 is headquartered in the biotech hub of San Diego, CA, with operations also in New York City, providing proximity to leading investigators and scientific talent on both coasts of the U.S.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment 858 Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for 858 Therapeutics's next move

See what Strategic adds

858 Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.